We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Contempo 1999 |

Prescribing for Seniors:  Neither Too Much nor Too Little

Paula A. Rochon, MD, MPH, FRCPC; Jerry H. Gurwitz, MD
JAMA. 1999;282(2):113-115. doi:10.1001/jama.282.2.113.
Text Size: A A A
Published online


Over the past few years the pendulum has swung from concern about the risks of excessive prescribing of inappropriate or unnecessary drug therapy to concerns about the consequences of underprescribing of potentially beneficial therapies to seniors (65 years and older). Concerns about excess drug use are for good reason. Use of greater numbers of drug therapies, rather than age alone, has been associated with an increased risk of developing adverse drug reactions.1 Furthermore, prescribing additional drugs to treat drug-induced symptoms can lead to prescribing cascades that develop when an adverse drug reaction is misinterpreted as a new medical problem.2 However, prescribing strategies that seek to limit the number of drugs prescribed to elderly patients in the name of improving quality of care may be seriously misdirected. A broader view of prescribing for seniors recognizes that problems occur from both the overprescribing and underprescribing of drug therapies. The past few years have seen a number of studies, a handful of which are cited in this article, illustrating the adverse consequences associated with underprescribing of beneficial drug therapies. These studies point to a more complex model for assessing the quality of prescribing for seniors than simply counting the number of different medications that an elderly patient is receiving.


Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 80

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.